Antioxidants 12 (11), 19101930 (2023)
For those with hypermobility and EDS specifically, Id flag the following as the minimum due diligence before starting these medications: A thorough GI history and ideally gastric emptying assessment if theres any existing dysmotility Baseline muscle mass measurement (DEXA or similar) given the sarcopenia risk A clear plan for high-protein diet and resistance-based exercise to mitigate muscle loss Baseline bone density if theres any existing concern Consideration of the nutritional picture specific to hypermobility, since these drugs can affect appetite and nutrient absorption A conversation specifically about MCAS if thats a feature of your presentation The medication options for hypermobility and EDS are limited and often unsatisfying, and its entirely understandable why people are looking at something new with genuine curiosity
The most effective way to manage any side effects is to work directly with a qualified healthcare provider
Az antivirlis vdelemmel kapcsolatban viszont fontos megemlteni a D-vitamin jelents szerept is, ugyanis a D-vitamin olyan gnek kifejezdst tudja serkenteni, amelyeknek ksznheten nvekszik a szervezet GSH-szintje, s ezltal jelents szerepet tlthet be a lgti megbetegedsek megelzsben
A proper retatrutide titration schedule manages that tradeoff systematically
Legal Status of Peptides in Australia In Australia, peptides are regulated by the Therapeutic Goods Administration (TGA)